Home
About
Overview
Sharing Data
ORCID
Help
History (4)
AIDS Dementia Complex
Co-Principal Investigator
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Product Packaging
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Principal Investigator
Overview
researcher role of
Doescher, Mark
contributes to
Stephenson Cancer Center - Cancer Center Support Grant